Latest presentation, page-50

I'm going to have to watch this again - I didn't see any particular bad news (or good for that matter). I saw an information update aimed at brokers and potential new investors. I guess no news is frustrating to existing holders.

Affy should provide an uptick in revenue (agree small but regular from now on) and I did get the hint that there is high confidence around a future with POC1 but the speculators seem to have deserted biotechs for now (old favourites OBJ and AHZ and ADO all suffering a little or just stagnating).